Medicare Enrolled
Dr. Lowell Schmeltz, MD
Endocrinology · Farmington Hills, MI
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Schmeltz from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Schmeltz?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Schmeltz
Dr. Lowell Schmeltz is an endocrinology specialist in Farmington Hills, MI, with 20 years of NPI registration. Based on federal Medicare data, Dr. Schmeltz performed 2,217 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Schmeltz received a total of $1,256,610 from 63 pharmaceutical and/or device companies across 2385 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Schmeltz is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 17% volume in MI
$1,256,610 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗2,217
Medicare services
Top 17% in MI for endocrinology
Not available
Unique patients (not deduplicated)
$50
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
748 | $91 | $175 |
| Blood glucose test using hand-held instrument A test that measures the level of sugar in the blood using a portable device. The result helps monitor blood glucose levels. |
486 | $3 | $10 |
| Hemoglobin A1c test (diabetes monitoring) A blood test that measures your average blood sugar levels over the past two to three months. |
437 | $10 | $30 |
| Continuous glucose monitoring with interpretation This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results. |
226 | $27 | $70 |
| Ultrasound of head and neck soft tissue This procedure uses sound waves to create images of the soft tissues in the head and neck area. It allows for the visualization of structures beneath the skin without using radiation. |
166 | $81 | $220 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
66 | $119 | $250 |
| Ultrasound-guided fine needle aspiration biopsy, first lesion A biopsy procedure where a thin needle is used to collect tissue samples from a growth, guided by ultrasound imaging. This code applies to the first lesion or mass sampled during the session. |
46 | $109 | $200 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
16 | $57 | $110 |
| New patient office visit, complex (60-74 min) | 15 | $168 | $285 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
11 | $41 | $70 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$1,256,610
Total received (2018-2024)
Avg $179,516/year across 7 years
Top 0% in MI for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
63
Companies
2,385
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$156,008
2023
$135,674
2022
$159,058
2021
$200,203
2020
$154,313
2019
$268,937
2018
$182,416
Payments by company (2024)
SANOFI-AVENTIS U.S. LLC
$64,513
Lilly USA, LLC
$61,834
Dexcom, Inc.
$10,653
Abbott Laboratories
$8,729
Novo Nordisk Inc
$8,520
Insulet Corporation
$857
Amgen Inc.
$207
ABBVIE INC.
$121
Corcept Therapeutics
$100
Boehringer Ingelheim Pharmaceuticals, Inc.
$76
Amphastar Pharmaceuticals, Inc.
$55
Mannkind Corporation
$47
Amneal Pharmaceuticals LLC
$47
Medtronic, Inc.
$40
PFIZER INC.
$36
Tolmar, Inc.
$35
Alvogen Inc
$33
Kyowa Kirin, Inc.
$25
Ascensia Diabetes Care Us Inc.
$20
Xeris Pharmaceuticals, Inc.
$17
Chiesi USA, Inc.
$15
Novartis Pharmaceuticals Corporation
$15
CeQur Corporation
$13
Top 3 companies account for 87.8% of 2024 payments
All-time payments by company (2018-2024) ›
Lilly USA, LLC
$631,725
Novo Nordisk Inc
$306,202
SANOFI-AVENTIS U.S. LLC
$80,393
Boehringer Ingelheim Pharmaceuticals, Inc.
$76,394
Abbott Laboratories
$51,351
Dexcom, Inc.
$45,509
Merck Sharp & Dohme Corporation
$17,502
Bayer HealthCare Pharmaceuticals Inc.
$17,327
DEXCOM, INC.
$8,739
Xeris Pharmaceuticals, Inc.
$8,660
Insulet Corporation
$3,871
VistaPharm, Inc.
$2,750
Amgen Inc.
$1,205
AstraZeneca Pharmaceuticals LP
$699
Amneal Pharmaceuticals LLC
$314
Janssen Pharmaceuticals, Inc
$306
Becton, Dickinson and Company
$301
AbbVie Inc.
$236
Corcept Therapeutics
$182
ABBVIE INC.
$179
Radius Health, Inc.
$173
PFIZER INC.
$172
Mannkind Corporation
$162
AbbVie, Inc.
$154
Medtronic MiniMed, Inc.
$151
MannKind Corporation
$132
Amryt Pharma Holdings Ltd
$128
Ascendis Pharma Inc
$107
Tandem Diabetes Care, Inc.
$107
Nevro Corp.
$106
Shire North American Group Inc
$89
Bayer Healthcare Pharmaceuticals Inc.
$87
LIFESCAN, INC.
$85
Alvogen Inc
$84
Ipsen Biopharmaceuticals, Inc
$74
Medtronic, Inc.
$66
RECORDATI_RARE_DISEASES_INC.
$60
Horizon Therapeutics plc
$57
Amphastar Pharmaceuticals, Inc.
$55
Ultragenyx Pharmaceutical Inc.
$53
CeQur Corporation
$49
Alexion Pharmaceuticals, Inc.
$48
Antares Pharma, Inc.
$44
Zealand Pharma US, Inc.
$42
Strongbridge US INC.
$40
IBSA Pharma Inc.
$39
EUSA Pharma (US) LLC
$35
Tolmar, Inc.
$35
Takeda Pharmaceuticals U.S.A., Inc.
$33
Novartis Pharmaceuticals Corporation
$32
Valeritas, Inc.
$31
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$26
Kyowa Kirin, Inc.
$25
LifeScan, Inc.
$25
Esperion Therapeutics, Inc.
$22
Companion Medical, Inc.
$21
Ascensia Diabetes Care Us Inc.
$20
Roche Diabetes Care, Inc.
$20
Allergan Inc.
$20
Merck Sharp & Dohme LLC
$17
Gilead Sciences, Inc.
$16
Chiesi USA, Inc.
$15
Aytu BioScience, Inc
$11
Top 3 companies account for 81.0% of all-time payments
Associated products mentioned in payments ›
ACCURIAN · AFREZZA · Androgel · BAQSIMI · BD NANO · BD Nano · BD Nano 2nd Gen Pen Needle · CYCLOSET · CeQur Simplicity · Corlanor · Crysvita · DC ACCU-CHEK Aviva Connect Kits and Accessories · DEXCOM CGM · DEXCOM G6 CGM SYSTEM · DEXCOM G6 TRANSMITTER · DEXCOM G7 GSS (161) · Dexcom CGM · Dexcom G6 Transmitter · EVENITY · EVERSENSE E3 SENSOR KIT - RETAIL · FARXIGA · FIASP · FORTEO · FREESTYLE INSULINX · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre · FreeStyle Libre 2 · FreeStyle Libre Pro · FreeStyle Libre blood glucose Flash Monitoring System · GVOKE HYPOPEN · GVOKE PFS · HUMULIN · HUMULIN R 500 · HUMULIN U · INVOKANA · InPen · JANUVIA · JARDIANCE · JATENZO · Kerendia · Korlym · LEQVIO · Levemir · MACRILEN · MINIMED 780G · MOUNJARO · MYCAPSSA · Macrilen · Minimed 670G System · NATPARA · NATPARA (PARATHYROID HORMONE) · NEXLETOL · Natesto · ONETOUCH VERIO FLEX · ONETOUCH VERIO REFLECT · OT Verio Flex Starter Kit · OT Verio Reflect "One Touch Meter and Strips" · OTREXUP · Omnia · Omnipod · Otrexup · Ozempic · PRALUENT · PROCLAIM · Prolia · RECORLEV · RYBELSUS · Repatha · Rybelsus · SIGNIFOR LAR · SOLIQUA · SOLIQUA 100/33 · SOMATULINE DEPOT · SOMAVERT · SOTAGLIFLOZIN · STEGLATRO · STRENSIQ · SYNTHROID · Saxenda · Senza · Somatuline Depot · Strensiq · Sylvant · Synthroid · TEPEZZA · TERIPARATIDE · TOUJEO · TRADJENTA · TRULICITY · TZIELD · Thyquidity · Tirosint · Tresiba · Tymlos · UNITHROID · V-GO · Victoza · Wegovy · XARELTO · Xultophy 100/3.6 · ZEGALOGUE · ZENPEP · t-slim insulin pump
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Endocrinologists in nearby ZIP areas
100
County median income
$95,296
Nearest hospital to ZIP centroid (approximate)
BEAUMONT HOSPITAL - FARMINGTON HILLS
2.9 mi
2.9 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Schmeltz is a clinical cardiology specialist, with above-average Medicare volume (top 17% in MI), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Schmeltz experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Schmeltz performed 748 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Schmeltz receive payments from pharmaceutical companies?
Yes. Dr. Schmeltz received a total of $1,256,610 from 63 companies across 2,385 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Schmeltz's costs compare to other endocrinologists in Farmington Hills?
Dr. Schmeltz's average Medicare payment per service is $50. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Schmeltz) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Endocrinology
Common procedures, typical costs, and what industry payments mean in endocrinology.
Same specialty & city
Endocrinologists in Farmington Hills
Browse endocrinologists in Farmington Hills ranked by procedure volume and transparency data.
Highest volume
Top Endocrinologists in MI
Endocrinologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Endocrinologists in MI
Which MI endocrinologists receive the most from drug and device companies.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
SANOFI-AVENTIS U.S. LLC Payments to Doctors
See all physicians who received payments from SANOFI-AVENTIS U.S. LLC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology